The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect ...

Diabetes is one of the fastest-growing health problems in the world, and millions of people rely on medication every day to ...

Diabetes can also weaken the brain's protective barrier, letting harmful substances in. This leads to inflammation. Reduced ...

New research has revealed exciting news for people with type 2 diabetes and chronic kidney disease. A medication called ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect brain health and vice versa. At such a critical moment in US history, we need ...

A randomized trial of in-hospital initiation of an SGLT2 inhibitor in patients with heart failure missed its endpoint, but a ...

Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and ...

Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for ...

Maze Therapeutics (MAZE) announced positive clinical results from the Phase 1 healthy volunteer study of MZE782, an oral small molecule targeting ...

As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways ...